Episode
International omicron multiplication
- Podcast
- Dr. John Campbell
- Published
- Jun 23, 2026
- Duration seconds
- 1740
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/VG9852043144.mp3?updated=1775725890
Actions
POST https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/international-omicron-multiplication/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/dr-john-campbell-7851784/international-omicron-multiplication.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Link for free download of John's two text books, http://159.69.48.3/ Campbell's Pathophysiology Notes, Amazon orders for the UK, https://www.amazon.co.uk/dp/B012HWC8SU/ref=cm_sw_em_r_mt_dp_AYC5Q7G3H2B3T4BCHQY0 Campbell's Physiology Notes https://www.amazon.co.uk/dp/0955379725/ref=cm_sw_em_r_mt_dp_K0MXMAP26Y77TY4J90FB the disease is mild in almost all of the cases seen so far, Dr Rochelle Walensky, CDC https://www.theguardian.com/world/2021/dec/09/cdc-chief-omicron-mild-early-data-us-spread-variant 75% of US cases vaccinated Scotland, 'tsunami' of Omicron https://www.dailymail.co.uk/news/article-10295867/Omicron-infecting-4-000-BRITONS-day.html Families in Scotland, to self-isolate for 10 days if one member tests positive, regardless of their vaccination status and even if they initially get a negative PCR test UK Government working on a 'Plan C' UK, Health Security Agency https://twitter.com/UKHSA/status/1468951053903142913?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet https://www.gov.uk/government/news/covid-19-variants-identified-in-the-uk Omicron is displaying a significant growth advantage over Delta, likely to outcompete Delta in the UK and become the dominant variant. If the growth rate and doubling time continue, at least 50% of coronavirus (COVID-19) cases to be caused by Omicron variant by mid-December One million by end of December 1% = 10,000 Omicron displays a reduction in protection offered by having had a previous infection or vaccination. There is insufficient data to make any assessment of protection against severe disease, or to assess the severity of illness caused by Omicron. Further studies are underway in the UK and abroad. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1039644/Omicron_SGTF_c…